StonvexLoading…
StonvexStonvexStonvexCore line items from AUPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $81.29M | $77.70M | $283.06M | $73.47M | $70.01M |
Operating Income | Not available | $41.42M | $104.91M | $29.75M | $20.08M |
Net Income | Not available | $34.35M | $287.20M | $31.55M | $21.51M |
EPS (Diluted) | $0.25 | $0.25 | $2.07 | $0.23 | $0.16 |
Total Assets | Not available | $724.00M | $751.59M | $527.53M | $502.56M |
Total Liabilities | Not available | $156.37M | $170.26M | $161.76M | $167.26M |
Cash & Equivalents | Not available | $40.75M | $80.16M | $72.89M | $52.91M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 130.77M | 132.32M | 131.84M | 132.67M |